Express Scripts (NASDAQ:ESRX) had its target price raised by equities researchers at Maxim Group from $78.00 to $87.00 in a note issued to investors on Thursday. The firm currently has a “buy” rating on the stock. Maxim Group’s target price indicates a potential upside of 26.88% from the company’s previous close.
Several other equities research analysts have also issued reports on the stock. Robert W. Baird increased their price objective on shares of Express Scripts from $57.00 to $59.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 25th. Jefferies Group set a $72.00 price target on shares of Express Scripts and gave the company a “buy” rating in a report on Tuesday, August 29th. Zacks Investment Research lowered shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Royal Bank of Canada set a $66.00 price target on shares of Express Scripts and gave the company a “hold” rating in a report on Wednesday, October 25th. Finally, UBS lowered shares of Express Scripts from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Five equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Express Scripts has an average rating of “Hold” and a consensus price target of $71.76.
Shares of Express Scripts (NASDAQ:ESRX) traded up $0.01 on Thursday, hitting $68.57. 3,723,700 shares of the company traded hands, compared to its average volume of 4,108,701. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $38,830.53, a P/E ratio of 10.02, a price-to-earnings-growth ratio of 1.01 and a beta of 0.88. Express Scripts has a fifty-two week low of $55.80 and a fifty-two week high of $73.42.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.90. The company had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. Express Scripts’s revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.74 earnings per share. equities research analysts expect that Express Scripts will post 7.01 earnings per share for the current fiscal year.
In other news, CEO Timothy C. Wentworth acquired 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The shares were purchased at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the transaction, the chief executive officer now directly owns 98,628 shares in the company, valued at approximately $6,029,129.64. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in ESRX. Parkside Financial Bank & Trust increased its position in shares of Express Scripts by 0.3% in the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after acquiring an additional 23 shares in the last quarter. CAPROCK Group Inc. boosted its holdings in shares of Express Scripts by 0.9% during the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after purchasing an additional 33 shares during the period. Sandy Spring Bank boosted its holdings in shares of Express Scripts by 0.6% during the second quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock worth $413,000 after purchasing an additional 37 shares during the period. Honkamp Krueger Financial Services Inc. boosted its holdings in shares of Express Scripts by 0.8% during the second quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock worth $304,000 after purchasing an additional 38 shares during the period. Finally, Buckingham Asset Management LLC boosted its holdings in shares of Express Scripts by 0.6% during the second quarter. Buckingham Asset Management LLC now owns 8,874 shares of the company’s stock worth $567,000 after purchasing an additional 52 shares during the period. 88.44% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.americanbankingnews.com/2017/12/14/maxim-group-increases-express-scripts-esrx-price-target-to-87-00.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).